BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27388143)

  • 1. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine.
    Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP
    Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters.
    Li R; Mak WW; Li J; Zheng C; Shiu PH; Seto SW; Lee SM; Leung GP
    Front Pharmacol; 2022; 13():837555. PubMed ID: 35264969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
    Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).
    Playa H; Lewis TA; Ting A; Suh BC; Muñoz B; Matuza R; Passer BJ; Schreiber SL; Buolamwini JK
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5801-5804. PubMed ID: 25454272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
    Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
    Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
    Hammond JR
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.
    Miller SR; McGrath ME; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Mol Pharmacol; 2021 Dec; 100(6):548-557. PubMed ID: 34503974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter.
    Bone DB; Hammond JR
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3325-32. PubMed ID: 17921321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thiazolidinediones on equilibrative nucleoside transporter-1 in human aortic smooth muscle cells.
    Leung GP; Man RY; Tse CM
    Biochem Pharmacol; 2005 Aug; 70(3):355-62. PubMed ID: 15963471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Computational Approaches for Predicting Drug Interactions with Human Equilibrative Nucleoside Transporter 1.
    Miller SR; Lane TR; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Drug Metab Dispos; 2021 Jul; 49(7):479-489. PubMed ID: 33980604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors.
    Jouan E; Moreau A; Bruyere A; Alim K; Denizot C; Parmentier Y; Fardel O
    Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):625-635. PubMed ID: 34275128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of ENT1 and ENT2 Proteins at the Placental Barrier and Contribution of These Transporters to Ribavirin Uptake.
    Nishimura T; Sano Y; Takahashi Y; Noguchi S; Uchida Y; Takagi A; Tanaka T; Katakura S; Nakashima E; Tachikawa M; Maruyama T; Terasaki T; Tomi M
    J Pharm Sci; 2019 Dec; 108(12):3917-3922. PubMed ID: 31520644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
    Ward JL; Sherali A; Mo ZP; Tse CM
    J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2.
    Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M
    Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of equilibrative and concentrative nucleoside transporters in alveolar epithelial cells.
    Baba S; Yumoto R; Kawami M; Takano M
    Pharmazie; 2021 Sep; 76(9):416-421. PubMed ID: 34481531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury.
    Eckle T; Hughes K; Ehrentraut H; Brodsky KS; Rosenberger P; Choi DS; Ravid K; Weng T; Xia Y; Blackburn MR; Eltzschig HK
    FASEB J; 2013 Aug; 27(8):3078-89. PubMed ID: 23603835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basolateral uptake of nucleosides by Sertoli cells is mediated primarily by equilibrative nucleoside transporter 1.
    Klein DM; Evans KK; Hardwick RN; Dantzler WH; Wright SH; Cherrington NJ
    J Pharmacol Exp Ther; 2013 Jul; 346(1):121-9. PubMed ID: 23639800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation.
    Aherne CM; Collins CB; Rapp CR; Olli KE; Perrenoud L; Jedlicka P; Bowser JL; Mills TW; Karmouty-Quintana H; Blackburn MR; Eltzschig HK
    JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Export of RNA-derived modified nucleosides by equilibrative nucleoside transporters defines the magnitude of autophagy response and Zika virus replication.
    Shi SL; Fukuda H; Chujo T; Kouwaki T; Oshiumi H; Tomizawa K; Wei FY
    RNA Biol; 2021 Oct; 18(sup1):478-495. PubMed ID: 34382915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.